申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP0122019A2
公开(公告)日:1984-10-17
A novel prostaglandin analogue of the formula:
(wherein the symbol ◄ represents β-configuration, the dotted linie ----- represents a-configuration, and the double bond between (C13-C14 represents transconfiguration) and cyclodextrin clathrates thereof, and non-toxic salts thereof are useful for the treatment and/or prevention of diseases induced by platelet aggregation, such as thrombosis, or induced by cytodamage.
一种式如下的新型前列腺素类似物:
(其中符号◄代表β-构型,点划线----- 代表a-构型,(C13-C14之间的双键代表反式构型)及其环糊精凝块和无毒盐可用于治疗和/或预防由血小板聚集诱发的疾病,如血栓形成,或由细胞损伤诱发的疾病。